Search

everythinglearnresearchcommunity

for

Search:↓

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

A genetic marker linked to a type of hair loss was found in most patients studied.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.

Trichoscopy of the beard is useful for diagnosing frontal fibrosing alopecia in men.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

High-frequency ultrasound effectively evaluates and diagnoses frontal fibrosing alopecia.

FOXN1 duplication can cause excessive hair growth.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

Krt16-deficient mice help understand skin disorders like PC and FNEPPK.

Fibronectin is essential for hair follicle regeneration and may help rejuvenate aged skin.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

A new tool helps study hair follicle cells to develop better treatments for hair disorders.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Foxn1 is essential for hair pigmentation by directing pigment transfer to hair cells.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Fibronectin-attached cell sheets improve wound healing and are safe and effective.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

ITK inhibitors may effectively treat alopecia areata.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

A mutant FERONIA gene affects root hair growth at high temperatures.